MedPath

Treadmill Training in Infants At-Risk for Neuromotor Delay

Not Applicable
Completed
Conditions
Infant born with low birth weight (<1500g).
Periventricular leukomalacia.
Hypoxic-ischemic encephalopathy.
Neonatal seizures.
Neurodevelopmental delay.
Physical Medicine / Rehabilitation - Physiotherapy
Neurological - Other neurological disorders
Registration Number
ACTRN12612001060831
Lead Sponsor
Michigan University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
50
Inclusion Criteria

Mild to moderate hypo/hypertonia or developmental delay when examined by their pediatrician; no congenital musculoskeletal deficits or other genetic disorders.

Exclusion Criteria

Severe hypo/hypertonia, genetic disorders such as spina bifida or Down syndrome, and genetic musculoskeletal deficits.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcome 1: Age of onset of independent walking.[Timepoint: whenever families reported their infants being able to take 3 steps over ground.];Primary outcome 2: percent of alternating steps.[Timepoint: monthly from starting the training or entering the study until walking onset (termination of intervention), and 6 months follow-up for gait analysis.];Primary outcome 3: percent of toe contact (Video analysis of foot placement at the initiation of the stance phase in the treadmill step).[Timepoint: monthly from starting the training or entering the study until walking onset (termination of intervention), and 6 months follow-up for gait analysis.]
Secondary Outcome Measures
NameTimeMethod
Secondary outcome 1: Gross Motor Function Measure[Timepoint: Termination of the intervention: when the infant was observed walking 3 independent steps over ground. Same timepoint for the control group.];Secondary outcome 2: Motor development (Bayley motor)[Timepoint: Termination of the intervention: when the infant was observed walking 3 independent steps over ground. Same timepoint for the control group.];Secondary outcome 3: Cognitive development (Bayley mental)[Timepoint: Termination of the intervention: when the infant was observed walking 3 independent steps over ground. Same timepoint for the control group.];Secondary outcome 4: Spasticity (Ashworth)[Timepoint: Termination of the intervention: when the infant was observed walking 3 independent steps over ground. Same timepoint for the control group.]
© Copyright 2025. All Rights Reserved by MedPath